Sawgrass Asset Management LLC Catalyst Pharmaceuticals, Inc. Transaction History

Sawgrass Asset Management LLC

  • $955 Million
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 06, 2024
SELL
$11.78 - $17.29 $447 - $657
-38 Reduced 0.28%
13,705 $230,000
Q3 2023

Nov 13, 2023
SELL
$11.69 - $15.02 $30,405 - $39,067
-2,601 Reduced 15.91%
13,743 $160,000
Q2 2023

Jul 13, 2023
SELL
$11.5 - $18.08 $78,878 - $124,010
-6,859 Reduced 29.56%
16,344 $219,000
Q1 2023

May 09, 2023
BUY
$14.34 - $21.05 $5,979 - $8,777
417 Added 1.83%
23,203 $384,000
Q4 2022

Feb 09, 2023
BUY
$12.25 - $19.5 $148,629 - $236,593
12,133 Added 113.89%
22,786 $423,000
Q3 2022

Nov 09, 2022
SELL
$7.06 - $15.52 $32,017 - $70,383
-4,535 Reduced 29.86%
10,653 $137,000
Q2 2022

Aug 04, 2022
SELL
$6.23 - $8.57 $5,569 - $7,661
-894 Reduced 5.56%
15,188 $106,000
Q1 2022

May 18, 2022
BUY
$5.31 - $8.31 $85,395 - $133,641
16,082 New
16,082 $133,000
Q4 2021

Feb 03, 2022
SELL
$5.21 - $7.45 $113,083 - $161,702
-21,705 Closed
0 $0
Q3 2021

Nov 04, 2021
SELL
$4.85 - $6.04 $7,202 - $8,969
-1,485 Reduced 6.4%
21,705 $115,000
Q2 2021

Aug 05, 2021
BUY
$4.29 - $6.05 $99,485 - $140,299
23,190 New
23,190 $133,000
Q3 2020

Nov 02, 2020
SELL
$2.97 - $5.08 $32,283 - $55,219
-10,870 Closed
0 $0
Q2 2020

Jul 27, 2020
BUY
$3.48 - $5.05 $37,827 - $54,893
10,870 New
10,870 $50,000

Others Institutions Holding CPRX

# of Institutions
326
Shares Held
94.6M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.12B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Sawgrass Asset Management LLC Portfolio

Follow Sawgrass Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email